Literature DB >> 7779081

Activation of mitogen-activated protein kinase by the human prostaglandin EP3A receptor.

T H Burkey1, J W Regan.   

Abstract

Mitogen-activated protein (MAP) kinases are involved with cellular proliferation, and while the traditional activators of these kinases have been the growth factor receptors, recent data indicate that G-protein coupled receptors which inhibit adenylyl cyclase can activate MAP kinases as well. We have recently cloned an alternative splice variant of a human receptor for prostaglandin E2 (PGE2) which inhibits adenylyl cyclase and as been defined as the EP3A (Brit. J. Pharmacol. 112:377, 1994). In the present study the ability of this receptor to activate MAP kinase was examined. In crude lysates of COS-7 cells transfected with the human EP3A, 1 microM PGE2 stimulated MAP kinase activity approximately 1.3-fold with an EC50 of approximately 6 nM. Ion exchange chromatography followed by immunoblot analysis showed that the stimulation of MAP kinase activity co-fractionated with immunoreactive MAP-2 kinase (ERK1). This activation of MAP kinase activity by the EP3A receptor may explain the proliferative actions of PGE2 in some tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779081     DOI: 10.1006/bbrc.1995.1790

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Intraplantar PGE2 causes nociceptive behaviour and mechanical allodynia: the role of prostanoid E receptors and protein kinases.

Authors:  C A L Kassuya; J Ferreira; R F Claudino; J B Calixto
Journal:  Br J Pharmacol       Date:  2007-02-19       Impact factor: 8.739

2.  EP(3) prostanoid receptor isoforms utilize distinct mechanisms to regulate ERK 1/2 activation.

Authors:  Davelene D Israel; John W Regan
Journal:  Biochim Biophys Acta       Date:  2009-02-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.